Nepafenac Once Daily for Macular Edema - Study 2

NCT01872611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

819

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Proliferative Diabetic Retinopathy
Cataract

Interventions

DRUG: Nepafenac Ophthalmic Suspension, 0.3%
OTHER: Vehicle
DRUG: Prednisolone acetate

Sponsor

Alcon Research